Mavacamten Safety and Efficacy in a Heart Transplant Patient Exhibiting Hypertrophic Obstructive Cardiomyopathy Phenotype/Phenocopy

Presenter/Author Information

• Zaid Abood MD, Cardiovascular and Thoracic Services, Aurora St. Luke’s Medical Center, Advocate HealthFollow
• Muddasir Ashraf MD, Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
• Asad Ghafoor MD, Interventional Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
• Amanda Misicka RN, Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
• Patrycja Galazka MD, Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
• M Fuad Jan MBBS, MD, Interventional Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
• Arshad Jahangir MD, Electrophysiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
• A Jamil Tajik MD, Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow

Recommended Citation

Abood Z, Ashraf M, Ghafoor A, et al. Mavacamten Safety and Efficacy in a Heart Transplant Patient Exhibiting Hypertrophic Obstructive Cardiomyopathy Phenotype/Phenocopy. J Patient Cent Res Rev. 2024;11:257-258. doi: 10.17294/2330-0698.2137

Affiliations

Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers

Presentation Notes

Case report or series poster presentation at Scientific Day; May 22, 2024; Milwaukee, WI. https://institutionalrepository.aah.org/sciday/2024/casereportvirtual/1/

Document Type

Abstract